Antios Therapeutics
Atlanta
About Antios Therapeutics
Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its oral drug candidate for potentially curative treatment of HBV infections. Antios Therapeutics was founded by Abel De La Rosa, Douglas Mayers, and Idean Marvasty.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $200.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2021)
- Website: antiostherapeutics.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/antios-therapeutics-21418 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.